Kenya’s One Health AMR network moved from pilot fragments to a national decision tool
Kenya’s experience with antimicrobial resistance surveillance now reads less like a pilot project and more like an operating public health system. In 2018, the country’s surveillance footprint was still narrow and uneven. By 2025, the network had expanded to 30 sites across human, animal, and environmental health, creating a coordinated platform for detecting resistance patterns and turning those signals into action.
The scale-up matters because AMR surveillance is only as useful as the systems that carry the data. Isolated laboratory results can confirm a resistant organism, but they do not guide national stewardship unless they are collected consistently, reported across sectors, and interpreted in a way that reaches policy makers. Kenya’s transition from fragmented pilots to a coordinated One Health approach shows how surveillance can move from description to decision-making when governance, laboratory systems, and reporting pathways are built together.
Surveillance coverage widened, and the reporting chain matured with it
The most visible change was numerical: two human health surveillance sites grew into a network of 30 sites spanning human, animal, and environmental sectors. Behind that expansion was a broader shift in how the country organized its AMR response. National reports began integrating AMR, antimicrobial consumption, and antimicrobial use data, allowing surveillance to describe not only resistance trends but also the pressure shaping them.
That integration is clinically important. Resistance rarely emerges in a vacuum; it tracks with antimicrobial exposure, infection prevention gaps, and opportunities for transmission between patients, animals, and the environment. A surveillance system that captures all three domains can identify whether rising resistance reflects misuse, weak infection control, or cross-sector spread. Kenya’s experience suggests that these datasets become far more actionable when they are assembled in a single reporting architecture rather than left in separate institutional silos.
The reporting ecosystem also matured beyond internal use. Routine submissions to global platforms became more consistent, and the country produced dashboards, reports, and policy briefs that linked surveillance findings to stewardship, infection prevention and control, regulatory decisions, and policy development. Those outputs matter because surveillance data are often stranded at the point of collection. Here, the infrastructure appears to have supported movement from laboratory and field data toward products that government agencies could actually use.
One concrete shift stands out: AMR surveillance became part of routine decision-making rather than an occasional exercise in data compilation.
Governance and multisectoral coordination became part of the surveillance platform
The report places unusual emphasis on governance, and for good reason. One Health surveillance fails when human health, veterinary services, environmental sectors, and partner organizations operate in parallel without a shared structure for oversight. Kenya’s progress was tied to government-led governance arrangements and coordinated partner support, suggesting that durable AMR surveillance depends on formal ownership as much as on technical capacity.
This is where the country’s trajectory begins to look operational rather than aspirational. The programmatic learning described across the review points to a system in which technical systems and governance structures developed together. That alignment likely helped the surveillance network move beyond data collection toward policy relevance. When ministries and technical agencies share a framework for interpreting AMR signals, the data are more likely to influence stewardship guidance, regulatory action, and resource allocation.
External benchmarks reinforced that shift. World Health Organization Joint External Evaluation scores improved from limited to demonstrated capacity for surveillance and multisectoral coordination. Those scores do not capture every operational detail, but they do provide an external marker that the national system advanced in both data generation and intersectoral collaboration. In practical terms, the country moved closer to a model in which AMR surveillance is not owned by one sector alone, but embedded in a shared public health architecture.
Why the Kenyan model matters for low- and middle-income settings
Kenya’s path is relevant well beyond its borders because it addresses a recurring problem in low- and middle-income settings: surveillance systems are often built as projects rather than institutions. A project can generate strong pilot data, but when external support ends, reporting slows, site coverage contracts, and the system loses policy influence. The Kenyan experience suggests that continuity improves when surveillance is anchored in government structures and paired with predictable partner coordination.
The article also points to a more subtle lesson about data utility. Surveillance is not simply about counting resistant isolates. It becomes useful when it informs antimicrobial stewardship, strengthens infection prevention and control, supports regulatory action, and shapes policy decisions. That requires data products that are timely, interpretable, and aligned with the questions governments ask when deciding where to deploy resources.
The One Health model adds another layer of value because resistance moves across sectors. Human clinical data alone can miss zoonotic and environmental reservoirs. Animal and environmental surveillance can reveal transmission pathways that would otherwise remain hidden. Kenya’s expansion across those domains makes the system more capable of identifying where interventions may interrupt the spread of resistance rather than merely documenting it after the fact.
Sustaining the gains now depends on financing and routine data use
The strongest message in the Kenyan experience is not simply that surveillance expanded; it is that sustaining progress will require predictable financing and routine use of the data already being generated. Without stable funding, even well-designed systems can lose site coverage, staff continuity, and laboratory throughput. Without routine use, surveillance becomes a reporting exercise rather than a management tool.
Those two risks are linked. When data are used regularly for stewardship decisions, regulatory action, and policy review, the system becomes more likely to justify ongoing investment. When data sit unused, the case for financing weakens. Kenya’s experience shows how surveillance can gain institutional weight once governments and partners build a feedback loop between data collection and decision-making.
The report leaves one practical question hanging in plain sight: whether expanded coverage can be matched by durable domestic financing and a consistent cadence of data-driven action. The sites are there. The reporting pathways are stronger. The remaining challenge is keeping the system active enough to influence practice year after year, not just during a funded implementation window.